Spero Therapeutics, Inc. — All Filings
488 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | FORM 3 SUBMISSION | 0000899243-17-025143 | Nov 1, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-17-025142 | Nov 1, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-17-025140 | Nov 1, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-17-025137 | Nov 1, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-17-025134 | Nov 1, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-17-025133 | Nov 1, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-17-025131 | Nov 1, 2017 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-17-025130 | Nov 1, 2017 | — |
| CERTNAS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-17-009661 | Nov 1, 2017 | — |
| CT ORDER | — | 9999999997-17-009657 | Nov 1, 2017 | — |
| CORRESP | — | 0001193125-17-323912 | Oct 30, 2017 | — |
| CORRESP | — | 0001193125-17-323908 | Oct 30, 2017 | — |
| 8-A12B | 8-A12B | 0001193125-17-323902 | Oct 30, 2017 | — |
| S-1/A | S-1/A | 0001193125-17-315961 | Oct 23, 2017 | — |
| CORRESP | — | 0001193125-17-308910 | Oct 12, 2017 | — |
| S-1 | S-1 | 0001193125-17-305888 | Oct 6, 2017 | — |
| DRSLTR | — | 0000950123-17-008684 | Sep 29, 2017 | — |
| DRS/A | — | 0000950123-17-008682 | Sep 29, 2017 | — |
| DRS/A | — | 0001564590-17-018945 | Sep 22, 2017 | — |
| DRS | — | 0000950123-17-008253 | Aug 25, 2017 | — |
| D | — | 0001701108-17-000003 | Mar 21, 2017 | — |